BEYOND MEAT, INC.
For the period ended Mar 28, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 28, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
Note 6. Property, Plant and Equipment
The Company records property, plant, and equipment at cost and includes finance lease assets in Property, plant and equipment, net in its unaudited condensed consolidated balance sheets. A summary of property, plant, and equipment, net as of March 28, 2026 and December 31, 2025, is as follows:
| March 28, 2026 | December 31, 2025 | |
|---|---|---|
| (in thousands) | ||
| Machinery and equipment | $125,807 | $127,475 |
| Leasehold improvements | 16,960 | 16,885 |
| Building | 29,462 | 29,562 |
| Finance leases | 124,592 | 125,216 |
| Software | 2,675 | 2,688 |
| Furniture and fixtures | 900 | 900 |
| Vehicles | 595 | 595 |
| Land | 5,525 | 5,548 |
| Assets not yet placed in service | 8,432 | 6,371 |
| Total property, plant and equipment | $314,948 | $315,240 |
| Less: accumulated depreciation and amortization | 107,495 | 101,978 |
| Property, plant and equipment, net | $207,453 | $213,262 |
Depreciation and amortization expense in the three months ended March 28, 2026 and March 29, 2025 was $6.8 million and $7.4 million, respectively. Depreciation and amortization expense in the three months ended March 28, 2026 included $0.5 million in accelerated depreciation related to the Company’s remaining leasehold improvement assets in China unrelated to the assets held for sale. Of the total depreciation and amortization expense in the three months ended March 28, 2026, $3.8 million was recorded in cost of goods sold, $2.2 million was recorded in research and development expenses, and $0.8 million was recorded in SG&A expenses, in the Company’s unaudited condensed consolidated statement of operations.
Depreciation and amortization expense in the three months ended March 29, 2025 included $1.5 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China. Of the total depreciation and amortization expense in the three months ended March 29, 2025, $6.0 million (including $0.6 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension of the Company’s operational activities in China) was recorded in cost of goods sold, $1.3 million (including $0.9 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension of the Company’s operational activities in China) was recorded in research and development expenses, and $0.1 million was recorded in SG&A expenses, in the Company’s unaudited condensed consolidated statement of operations.
As of March 28, 2026 and December 31, 2025, the Company had $9.6 million and $9.4 million in property, plant and equipment, respectively, classified as assets held for sale.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.